Biotech 2050 Podcast cover image

Advancing Drug Discovery with Cutting-Edge AI & Team Synergy: Fabrice Chouraqui, CEO of Cellarity

Biotech 2050 Podcast

CHAPTER

Revolutionizing Drug Discovery with AI

This chapter delves into the innovative impact of artificial intelligence on drug development at Celerity, emphasizing a shift from isolated targets to broader cellular dysfunctions. It highlights the need for a multidisciplinary approach in forming effective teams that combine diverse expertise to fully leverage AI's capabilities in creating new treatments.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner